Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Swiss Exchange  >  Newron Pharmaceuticals SpA    NWRN   IT0004147952

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Newron Pharmaceuticals SpA
Discovers and develops small molecule drugs

Newron Pharmaceuticals SpA is a biopharmaceutical company focused on the development of novel therapies for patients with diseases of the Central Nervous System (CNS) and pain.

The focus of its treatments includes patients with Parkinson's disease, Rett Syndrome, Amyotrophic Lateral Sclerosis, schizoprenia, and neuropathic pain.

The company was founded by Luca Benatti, Ruggero Fariello, and Patricia Salvati in 1999 and is headquartered in Bresso, Italy.

Number of employees : 23 persons.
Sales per Businesses
20152016Delta
CHF (in Million)%CHF (in Million)%
Pharmaceutical Drugs2.43100%5.16100% +112.52%
Sales per Regions
20152016Delta
CHF (in Million)%CHF (in Million)%
Global2.43100%5.16100% +112.52%
Managers
NameAgeSinceTitle
Stefan Weber522005Chief Executive Officer, Director & IR Contact
Ulrich Köstlin, PhD652013Non-Executive Chairman
Roberto Galli-2002Vice President-Finance
Ravi Anand, MD602005Chief Medical Officer
Patrick J. Langlois, PhD722008Independent Non-Executive Director
Robert Leslie Holland MD, PhD622013Independent Non-Executive Director
Bo Jesper Hansen MD, PhD592013Independent Non-Executive Director
Joseph Donald deBethizy, PhD662014Independent Non-Executive Director
Luca Benatti, PhD562014Independent Non-Executive Director
Marco Caremi602002Executive Vice President-Business Development
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Share A 1 15,778,543 11,557,513 73.2% 0 0.0% 73.2%
Shareholders
NameEquities%
Investor AB 1,772,817 11.2%
Gefim SpA 1,311,957 8.31%
Aviva Plc 1,097,054 6.95%
JPMorgan Asset Management (UK) Ltd. 314,970 2.00%
UBS AG (Investment Management) 259,148 1.64%
Union Investment Privatfonds GmbH 149,140 0.95%
Polar Capital LLP 127,270 0.81%
Norges Bank Investment Management 121,793 0.77%
Aviva Investors Global Services Ltd. 121,616 0.77%
Credit Suisse AG 111,503 0.71%
Sector
Healthcare
Pharmaceuticals & Medical Research
 Biotechnology & Medical Research
  Biotechnology & Medical Research
   Bio Therapeutic Drugs
Advertisement
Sector Bio Therapeutic Drugs
1st jan.Capitalization (M$)
NEWRON PHARMACEUTICALS..5.71%345
AMGEN, INC.6.02%113 994
CELGENE CORPORATION0.89%91 185
GILEAD SCIENCES, INC.-9.93%84 284
REGENERON PHARMACEUTIC..23.99%48 380
ACTELION LTD24.38%30 602
VERTEX PHARMACEUTICALS..62.78%29 868
GENMAB A/S18.24%12 738
TESARO INC10.88%8 032
BIOVERATIV INC0.00%5 948
EXELIXIS, INC.29.78%5 660
HUALAN BIOLOGICAL ENGI..--.--%4 802
TONGHUA DONGBAO PHARMA..-5.43%4 304
KITE PHARMA INC63.05%4 134
NEUROCRINE BIOSCIENCES..19.43%4 071
BLUEBIRD BIO INC27.55%3 223
CHINA BIOLOGIC PRODUCT..6.29%3 109
PEPTIDREAM INC0.33%3 097
BIOCON LTD-0.58%2 916
INTERCEPT PHARMACEUTIC..3.22%2 805
BEIJING SL PHARMACEUTI..--.--%2 559
Sector Bio Therapeutic Drugs
Newron Pharmaceuticals SpA : Connections
EryDel SpA
Oxford Gene Technology IP Ltd.
White City Consulting ApS
Early Clinical Development Consulting Ltd.
Azanta A/S
Karolinska Development AB (Private Equity)
DFC Langlois
Constantia Flexibles Group GmbH
PJL Consulting
Wellington Partners GmbH
NOXXON Pharma AG
European School of Management & Technology GmbH
Assobiotec
Proterris, Inc.
Constantia Flexibles AG
Universitätsklinikum Würzburg
Orphazyme ApS
Italian Angels For Biotech
CMC Contrast AB
MipSalus ApS
The European Association for Bioindustries
Company contact information
Newron Pharmaceuticals SpA
via Ludovico Ariosto 21
Bresso, Milan 20091

Phone : +39.02.610.3461
Fax : +39.02.610.34654
Web : www.newron.com
© 2017 People , Fundamentals and Ownership